{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T14:18:03Z","timestamp":1777299483252,"version":"3.51.4"},"reference-count":13,"publisher":"The Endocrine Society","issue":"3","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Neonatal diabetes mellitus (NDM) often requires insulin treatment to maintain adequate glycemic control and support growth and development. Conventional insulin treatment regimens are particularly challenging in NDM due to young age, developmentally appropriate feeding variation, and heightened insulin sensitivity leading to very small insulin dosing. We present this case as\u2014to our knowledge\u2014the earliest implementation of a hybrid closed-loop (HCLS) automated insulin delivery system in an NDM patient. HCLS with U10 significantly improved glycemic control compared to conventional insulin delivery with minimization of hypoglycemia. The adaptive capabilities of HCLS allowed for developmentally appropriate, ad libitum feeding without carbohydrate quantification, resulting in a meaningful quality of life improvement. This case adds to evidence supporting safe and effective use of diabetes technology in very young children. It demonstrates that the benefits seen in older populations can be achieved in neonatal patients and supports expanding clinical use of HCLS systems in this setting.<\/jats:p>","DOI":"10.1210\/jcemcr\/luaf338","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T12:42:33Z","timestamp":1767184953000},"source":"Crossref","is-referenced-by-count":1,"title":["Implementation of a Hybrid Closed-Loop Automated Insulin Delivery System in a 29-Day Infant With Neonatal Diabetes"],"prefix":"10.1210","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7377-7820","authenticated-orcid":false,"given":"Alexandra L","family":"Ghaben","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Division of Endocrinology, University of California , San Diego, CA 92093-0734 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Byer-Mendoza","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Rady Children's Hospital , San Diego, CA 92123-4282 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly","family":"McNamara","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Rady Children's Hospital , San Diego, CA 92123-4282 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Huber","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Rady Children's Hospital , San Diego, CA 92123-4282 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna L","family":"Cymbaluk","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Endocrinology, University of California , San Diego, CA 92093-0734 ,","place":["USA"]},{"name":"Department of Endocrinology, Rady Children's Hospital , San Diego, CA 92123-4282 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6541-8534","authenticated-orcid":false,"given":"Puja","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Endocrinology, University of California , San Diego, CA 92093-0734 ,","place":["USA"]},{"name":"Department of Endocrinology, Rady Children's Hospital , San Diego, CA 92123-4282 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"issue":"1","key":"2026022405213964200_luaf338-B1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.clp.2017.10.006","article-title":"Neonatal Diabetes Mellitus: an update on diagnosis and management","volume":"45","author":"Lemelman","year":"2018","journal-title":"Clin Perinatol"},{"issue":"3","key":"2026022405213964200_luaf338-B2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1210\/er.2007-0029","article-title":"Neonatal Diabetes Mellitus","volume":"29","author":"Aguilar-Bryan","year":"2008","journal-title":"Endocr Rev"},{"issue":"6","key":"2026022405213964200_luaf338-B3","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1159\/000543156","article-title":"International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus guidelines 2024 diabetes technologies: glucose monitoring","volume":"97","author":"Tauschman","year":"2025","journal-title":"Horm Res Paediatr"},{"issue":"6","key":"2026022405213964200_luaf338-B4","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1159\/000543034","article-title":"International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus guidelines 2024: diabetes technologies \u2013 insulin delivery","volume":"97","author":"Biester","year":"2025","journal-title":"Horm Res Paediatr"},{"issue":"8","key":"2026022405213964200_luaf338-B5","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.2337\/dc22-0329","article-title":"Hybrid closed-loop systems and glycemic outcomes in children and adults with type 1 diabetes: real-world evidence from a U.S.-based multicenter collaborative","volume":"45","author":"Noor","year":"2022","journal-title":"Diabetes Care"},{"key":"2026022405213964200_luaf338-B6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2023\/8825724","article-title":"Management of neonatal diabetes due to a KCNJ11 mutation with automated insulin delivery system and remote patient monitoring","volume":"2023","author":"Lee","year":"2023","journal-title":"Case Rep Endocrinol"},{"issue":"10","key":"2026022405213964200_luaf338-B7","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.3390\/children11101225","article-title":"Safety and efficacy of using advanced hybrid closed loop off-label in an infant diagnosed with permanent Neonatal Diabetes Mellitus: a case report and a look to the future","volume":"11","author":"Pezzotta","year":"2024","journal-title":"Children"},{"issue":"3","key":"2026022405213964200_luaf338-B8","doi-asserted-by":"crossref","first-page":"176","DOI":"10.2337\/diaspect.29.3.176","article-title":"A novel approach to the management of neonatal diabetes using sensor-augmented insulin pump therapy with threshold suspend technology at diagnosis","volume":"29","author":"Marin","year":"2016","journal-title":"Diabetes Spectr"},{"issue":"6","key":"2026022405213964200_luaf338-B9","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/apa.15100","article-title":"Successful treatment of a cohort of infants with neonatal diabetes using insulin pumps including data on genetics and estimated incidence","volume":"109","author":"Torbj\u00f6rnsdotter","year":"2020","journal-title":"Acta Paediatr"},{"issue":"3","key":"2026022405213964200_luaf338-B10","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1297\/cpe.2022-0005","article-title":"Long-term sensor-augmented pump therapy for neonatal diabetes mellitus: a case series","volume":"31","author":"Fukuda","year":"2022","journal-title":"Clin Pediatr Endocrinol"},{"issue":"1","key":"2026022405213964200_luaf338-B11","doi-asserted-by":"crossref","first-page":"3624339","DOI":"10.1155\/pedi\/3624339","article-title":"Clinical characteristics and remission monitoring of 6q24-related transient neonatal diabetes","volume":"2024","author":"McCullough","year":"2024","journal-title":"Pediatr Diabetes"},{"issue":"10","key":"2026022405213964200_luaf338-B12","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.3390\/children9101541","article-title":"Neonatal hyperglycemia and neurodevelopmental outcomes in preterm infants: a review","volume":"9","author":"Guiducci","year":"2022","journal-title":"Children"},{"issue":"12","key":"2026022405213964200_luaf338-B13","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.3390\/life14121618","article-title":"Neonatal hypoglycemia and neurodevelopmental outcomes\u2014an updated systematic review and meta-analysis","volume":"14","author":"Diggikar","year":"2024","journal-title":"Life"}],"container-title":["JCEM Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/4\/3\/luaf338\/67089140\/luaf338.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/4\/3\/luaf338\/67089140\/luaf338.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T10:21:43Z","timestamp":1771928503000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcemcr\/article\/doi\/10.1210\/jcemcr\/luaf338\/8495824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,23]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2,23]]}},"URL":"https:\/\/doi.org\/10.1210\/jcemcr\/luaf338","relation":{},"ISSN":["2755-1520"],"issn-type":[{"value":"2755-1520","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2026,2,23]]},"article-number":"luaf338"}}